On February 27, 2024, Qualigen Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 USD | +1.55% | -0.10% | -46.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.36% | 1.86M | |
+1.77% | 42.86B | |
+12.24% | 42.74B | |
+44.02% | 41.36B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- QLGN Stock
- News Qualigen Therapeutics, Inc.
- Qualigen Therapeutics, Inc. announced that it has received $0.55 million in funding from Alpha Capital Anstalt